Výsledky vyhledávání - "Susan G Kozauer"

The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses

Autor: Roger S. McIntyre, Suresh Durgam, Susan G. Kozauer, Richard Chen, Jason Huo, Robert E. Davis, Andrew J. Cutler

Publikováno v: European Neuropsychopharmacology. 68:78-88

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28e978d56ce6917e7f8731e04b123006
https://doi.org/10.1016/j.euroneuro.2022.12.012

Zobrazit plný text záznamu

The Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed Features

Autor: Roger S. McIntyre, Suresh Durgam, Jason Huo, Susan G. Kozauer, Stephen M. Stahl

Publikováno v: The Journal of Clinical Psychiatry. 84

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ce860c0c2eb3c585c6d2eb1e450f729
https://doi.org/10.4088/jcp.22m14739

Zobrazit plný text záznamu

Adjunctive lumateperone ( ITI ‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial

Autor: Trisha Suppes, Suresh Durgam, Susan G. Kozauer, Richard Chen, Hassan D. Lakkis, Robert E. Davis, Andrew Satlin, Kimberly E. Vanover, Sharon Mates, Roger S. McIntyre, Mauricio Tohen

Publikováno v: Bipolar Disorders.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::782c8b69f8de58be03b94a3fd3503c74
https://doi.org/10.1111/bdi.13310

Zobrazit plný text záznamu

Metabolic Syndrome in Bipolar Depression with Lumateperone (ITI-007): A Post Hoc Analysis of 2 Randomized, Placebo-Controlled Trials

Autor: Christoph U Correll, Susan G Kozauer, Micah Lands, Jason Huo, Suresh Durgam

Publikováno v: CNS Spectrums. 28:247-248

IntroductionTreatments for bipolar disorder are often associated with increased rates of metabolic syndrome (MetSy). MetSy is defined as meeting 3 of the following 5 criteria: waist circumference >40in (men) or >35in (women), triglycerides ≥150mg/d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::abf19d3623cffe9a6de127d9e8eb53c3
https://doi.org/10.1017/s1092852923001852

Zobrazit plný text záznamu

Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression

Autor: John B Edwards, Suresh Durgam, Susan G Kozauer, Rakesh Jain, Roger S McIntyre

Publikováno v: CNS Spectrums. 28:238-238

IntroductionIn patients with bipolar disorder, depression symptoms are associated with greater reduction in function and quality of life than hypomania/mania symptoms. Lumateperone (LUMA), is an FDA-approved antipsychotic to treat schizophrenia and d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d4bf4ca3527c0914ea8262ca5dd13c4
https://doi.org/10.1017/s1092852923001682

Zobrazit plný text záznamu